Skip to main content
Erschienen in: European Surgery 5/2015

01.10.2015 | Original Article

Outcome of anal and rectal melanoma: has site of origin a prognostic value? Analysis of 287 patients

verfasst von: A. Ciarrocchi, R. Pietroletti, F. Carlei, G. Amicucci

Erschienen in: European Surgery | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Summary

Introduction

To investigate the prognostic role of site of origin for primary anorectal melanoma.

Methods

Data regarding patients affected by primary melanoma of the anal canal and rectum were retrieved from the surveillance, epidemiology, and end results database. Age, gender, tumor stage, tumor location, receipt of radiotherapy, and type of surgical intervention were introduced as covariates in a Cox proportional hazards regression model.

Results

Our population constituted of 177 patients affected by anal canal melanoma and 110 by rectal melanoma. Tumor stage resulted to be the only independent predictor of survival (P = 0.002; hazards ratio 1.819; 95 % confidence interval 1.255–2.636). Tumor location failed to reach statistical significance.

Conclusion

Site of origin of anorectal melanoma does not affect overall survival in patients undergoing surgery.
Literatur
1.
Zurück zum Zitat Thibault C, Sagar P, Nivatvongs S, et al. Anorectal melanoma–an incurable disease? Dis Colon Rectum. 1997;40:661–8.CrossRefPubMed Thibault C, Sagar P, Nivatvongs S, et al. Anorectal melanoma–an incurable disease? Dis Colon Rectum. 1997;40:661–8.CrossRefPubMed
2.
Zurück zum Zitat Miguel I, Freire J, Passos MJ, Moreira A. Anorectal malignant melanoma: retrospective analysis of management and outcome in a single Portuguese Institution. Med Oncol. 2015;32:445.CrossRefPubMed Miguel I, Freire J, Passos MJ, Moreira A. Anorectal malignant melanoma: retrospective analysis of management and outcome in a single Portuguese Institution. Med Oncol. 2015;32:445.CrossRefPubMed
3.
Zurück zum Zitat Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664–78.CrossRefPubMed Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664–78.CrossRefPubMed
4.
Zurück zum Zitat Helmke BM, Mollenhauer J, Herold-Mende C, Benner A, et al. BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level. Gastroenterology. 2004;6:1815–20.CrossRef Helmke BM, Mollenhauer J, Herold-Mende C, Benner A, et al. BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level. Gastroenterology. 2004;6:1815–20.CrossRef
5.
Zurück zum Zitat Lachiewicz AM, Berwick M, Wiggins C, Thomas ME. Survival differences between patients with scalp or neck Melanoma and those with melanoma of other sites in the surveillance, epidemiology, and end results (SEER) program. Arch Dermatol. 2008;144:515–21.CrossRefPubMed Lachiewicz AM, Berwick M, Wiggins C, Thomas ME. Survival differences between patients with scalp or neck Melanoma and those with melanoma of other sites in the surveillance, epidemiology, and end results (SEER) program. Arch Dermatol. 2008;144:515–21.CrossRefPubMed
6.
Zurück zum Zitat Smyth EC, Flavin M, Barbi A, et al. Memorial Sloan-Kettering Cancer Center (MSKCC) single institutional vulvovaginal mucosal melanoma (VVMM) experience from 1995 to 2010. Eur J Cancer. 2011;47:S661.CrossRef Smyth EC, Flavin M, Barbi A, et al. Memorial Sloan-Kettering Cancer Center (MSKCC) single institutional vulvovaginal mucosal melanoma (VVMM) experience from 1995 to 2010. Eur J Cancer. 2011;47:S661.CrossRef
7.
Zurück zum Zitat Keller DS, Thomay AA, Gaughan J, Olszanski A, et al. Outcomes in patients with mucosal melanomas. J Surg Oncol. 2013;8:516–20.CrossRef Keller DS, Thomay AA, Gaughan J, Olszanski A, et al. Outcomes in patients with mucosal melanomas. J Surg Oncol. 2013;8:516–20.CrossRef
8.
Zurück zum Zitat Cagir B, Whiteford MH, Topham A, Rakinic J, Fry RD. Changing epidemiology of anorectal melanoma. Dis Colon Rectum. 1999;42:1203–8.CrossRefPubMed Cagir B, Whiteford MH, Topham A, Rakinic J, Fry RD. Changing epidemiology of anorectal melanoma. Dis Colon Rectum. 1999;42:1203–8.CrossRefPubMed
9.
11.
12.
Zurück zum Zitat Droesch JT, Flum DR, Mann GN. Wide local excision or abdominoperineal resection as the initial treatment for anorectal melanoma? Am J Surg. 2005;189:446–9.CrossRefPubMed Droesch JT, Flum DR, Mann GN. Wide local excision or abdominoperineal resection as the initial treatment for anorectal melanoma? Am J Surg. 2005;189:446–9.CrossRefPubMed
13.
Zurück zum Zitat Yeh JJ, Shia J, Hwu WJ, Busam KJ, et al. The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg. 2006;244:1012–7.PubMedCentralCrossRefPubMed Yeh JJ, Shia J, Hwu WJ, Busam KJ, et al. The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg. 2006;244:1012–7.PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Belli F, Gallino GF, Vullo S L, Mariani L, et al. Melanoma of the anorectal region: the experience of the National Cancer Institute of Milano. Eur J Surg Oncol. 2009;35:757–62.CrossRefPubMed Belli F, Gallino GF, Vullo S L, Mariani L, et al. Melanoma of the anorectal region: the experience of the National Cancer Institute of Milano. Eur J Surg Oncol. 2009;35:757–62.CrossRefPubMed
15.
Zurück zum Zitat Meguerditchian AN, Meterissian SH, Dunn KB. Anorectal melanoma: diagnosis and treatment. Dis Colon Rectum. 2011;54:638–44.CrossRefPubMed Meguerditchian AN, Meterissian SH, Dunn KB. Anorectal melanoma: diagnosis and treatment. Dis Colon Rectum. 2011;54:638–44.CrossRefPubMed
16.
Zurück zum Zitat Nilsson PJ, Ragnarsson-Olding BK. Importance of clear resection margins in anorectal malignant melanoma. Br J Surg. 2010;97:98–103.CrossRefPubMed Nilsson PJ, Ragnarsson-Olding BK. Importance of clear resection margins in anorectal malignant melanoma. Br J Surg. 2010;97:98–103.CrossRefPubMed
17.
Zurück zum Zitat Iddings DM, Fleisig AJ, Chen SL, Faries MB, et al. Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients? Ann Surg Oncol. 2010;17:40–4.PubMedCentralCrossRefPubMed Iddings DM, Fleisig AJ, Chen SL, Faries MB, et al. Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients? Ann Surg Oncol. 2010;17:40–4.PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Podnos YD, Tsai NC, Smith D, Ellenhorn JD. Factors affecting survival in patients with anal melanoma. Am Surg. 2006;72:917–20.PubMed Podnos YD, Tsai NC, Smith D, Ellenhorn JD. Factors affecting survival in patients with anal melanoma. Am Surg. 2006;72:917–20.PubMed
Metadaten
Titel
Outcome of anal and rectal melanoma: has site of origin a prognostic value? Analysis of 287 patients
verfasst von
A. Ciarrocchi
R. Pietroletti
F. Carlei
G. Amicucci
Publikationsdatum
01.10.2015
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 5/2015
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-015-0348-2

Weitere Artikel der Ausgabe 5/2015

European Surgery 5/2015 Zur Ausgabe